Jenny Yip

Excited for what’s to come!

Jenny Yip

Excited for what’s to come!

San Francisco, California

Overview

Jenny Yip is a highly accomplished professional currently serving as the Managing Partner at Adjuvant Capital, where she oversees investments in companies such as Antiva Biosciences and Evofem Biosciences. With a background in financial modeling and investment banking, Jenny has held influential roles on boards and committees for organizations like Global Fund for Women and ReSurge International, showcasing her expertise in corporate finance and strategic investments.

Work Experience

Global Fund for Women

Member Board of Trustees
2024 - Current

Stand With Women. Stand With Us.

globalfundforwomen.org

ReSurge International

Director
2022

ReSurge International is a surgical care facility for poor children and adults who lack access to healthcare.

resurge.org

Harvard School of Public Health Magazine

Advisory Board Member
2022

RH Capital

Investment Advisory Committee Member
2018

RH Capital is an impact-first venture capital firm that invests in early-stage startups.

rhcapital.vc

Antiva Biosciences, Inc.

Director
2021 - 2024

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Raised $140,346,025.00 from HBM Partners, Lumira Ventures, Google Ventures, Canaan Partners, Sofinnova Investments, Adjuvant Capital and BioImpact Capital.

antivabio.com